Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.270
-0.225 (-15.05%)
At close: Aug 7, 2025, 4:00 PM
1.290
+0.020 (1.57%)
After-hours: Aug 7, 2025, 7:56 PM EDT
Theseus Pharmaceuticals Stock Forecast
LGVN's stock price has decreased by -56.06% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $8.67, which forecasts a 582.68% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $10.
Price Target: $8.67 (+582.68%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 21, 2025.
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +687.40% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +687.40% | Mar 3, 2025 |
| Roth MKM | Roth MKM | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +687.40% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +687.40% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +687.40% | Nov 4, 2024 |
Financial Forecast
Revenue This Year
1.76M
from 2.39M
Decreased by -26.34%
Revenue Next Year
2.67M
from 1.76M
Increased by 51.48%
EPS This Year
-1.33
from -2.62
EPS Next Year
-1.20
from -1.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.0M | 4.2M | 41.1M |
| Avg | 1.8M | 2.7M | 39.9M |
| Low | 1.6M | 1.9M | 38.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -17.4% | 138.4% | 1,438.9% |
| Avg | -26.3% | 51.5% | 1,394.9% |
| Low | -34.4% | 6.4% | 1,336.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.19 | -0.92 | -0.24 |
| Avg | -1.33 | -1.20 | -0.23 |
| Low | -1.45 | -1.42 | -0.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.